SOLIDEX®-ISOEx Anti-G4S Linker Nanobeads (Column-Based) (Cat No.:GMLS-Tag003-Ab01-nanoIMB)


Paramagnetic 50 nm nanobeads directly conjugated with a highly specific monoclonal antibody targeting the classic (GGGGS)n flexible linker (G4S linker) within the single-chain variable fragment (scFv) of CAR constructs. Designed for the high-purity, column-based magnetic enrichment or depletion of G4S-containing CAR-expressing immune cells.
Check GeneMedi's SOLIDEX™-ISOEx Cell Isolation Kit & Nanobeads


pdfCOA

Order information


Catalog No. Product Name Size Price(In USD)
GMLS-Tag003-Ab01-nanoIMB-0.5mL SOLIDEX®-ISOEx Anti-G4S Linker Nanobeads (Column-Based) 0.5 mL
GMLS-Tag003-Ab01-nanoIMB-1mL SOLIDEX®-ISOEx Anti-G4S Linker Nanobeads (Column-Based) 1 mL

Description


Cat No. GMLS-Tag003-Ab01-nanoIMB
Product Name SOLIDEX®-ISOEx Anti-G4S Linker Nanobeads (Column-Based)
Description Paramagnetic 50 nm nanobeads directly conjugated with a highly specific monoclonal antibody targeting the classic (GGGGS)n flexible linker (G4S linker) within the single-chain variable fragment (scFv) of CAR constructs. Designed for the high-purity, column-based magnetic enrichment or depletion of G4S-containing CAR-expressing immune cells.
Application Universal CAR Cell Enrichment: Direct, antigen-independent isolation of G4S-based CAR-T, CAR-NK, or CAR-M cells. In Vitro Functional Assays: Preparation of highly purified CAR+ populations for activation, expansion, and functional screening. Translational Process Quality Control: Direct assessment and sorting of CAR+ yields within manufacturing processes.
Component for 5E8 cells (50Tests) / 1E9 cells(100tests) / 7.5E9 cells (750tests) GMLS-Tag003-Ab01-nanoIMB: SOLIDEX®-ISOEx Anti-G4S Linker Nanobeads (Column-Based)
Labeling Type Direct
Bead Type Non-releasable
Format Column-based
Key feature Excellent Column Compatibility: Seamlessly compatible with standard high-gradient magnetic columns, ensuring high recovery rates with minimal non-specific binding. Minimal Steric Hindrance: 50 nm sized particles prevent receptor cross-linking or steric blockades of target antigen-binding sites. Non-Destructive Technology: Biocompatible matrix ensures cells remain highly viable, fully functional, and ready for downstream cultivation.